• Tumor Suppressor Gene P53 (TP53) Gene Mutation Analysis
  • Cancer Antigen (CA) 19-9, Serum
  • Methylation Cancer Marker Detection in Cell-free Circulating Tumor DNA (Northstar Select and Response™)
  • Solid Tumor Gene Mutation Panel, NGS (Oncotype MAP™, Guardant360® CDx, Guardant Reveal™, PGDx elio™, Northstar Select®, oncoReveal™, LiquidHALLMARK®, PredicineATLAS™, PGDx elio™ Assay)
  • Gamma Glutamyl Transferase (GGT)
  • MSH6 Gene Mutation Analysis (Known Mutations, Duplication/Deletion/Sequencing)
  • LiquidHALLMARK Multi Cancer Panel
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /LiquidHALLMARK Multi Cancer Panel
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

LiquidHALLMARK Multi Cancer Panel
Medical Test

Interpretation
Access to LiquidHALLMARK Multi Cancer Panel is restricted.
Loading...